Advanced search
Start date
Betweenand

Louise Faggionato Kimura Vieira

CV Lattes ResearcherID ORCID


Secretaria da Saúde (São Paulo - Estado). Instituto Butantan  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

Louise Faggionato Kimura Vieira in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher
Novel formulation permits use of toxin extracted from rattlesnake venom to treat chronic pain 
Articles published in other media outlets (84 total):
More itemsLess items
UOL: Nova formulação permite usar toxina do veneno da cascavel para tratar dor (25/Apr/2020)
Espaço Ecológico no Ar: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
LabNetwork: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Planeta online: Toxina de veneno de cascavel consegue tratar dor crônica (23/Apr/2020)
Revista Pará: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Central das Notícias: Toxina de veneno de cascavel consegue tratar dor crônica (23/Apr/2020)
Fatos do Iguaçu online: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Diário da Região (São José do Rio Preto, SP) online: Nova formulação permite usar toxina do veneno de cascavel para tratar dor crônica (22/Apr/2020)
Portal da Enfermagem: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
JC Notícias (São Paulo, SP): Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
Atemporal: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
Agrosoft: NOVA FORMULAÇÃO PERMITE USAR TOXINA DO VENENO DA CASCAVEL PARA TRATAR DOR CRÔNICA (22/Apr/2020)
Blog A Crítica: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
News Break (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (11/Mar/2020)
Innovaspain (Espanha): Veneno de serpiente de cascabel para combatir el dolor crónico (11/Mar/2020)
Pregon Agropecuario (Argentina): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (10/Mar/2020)
NCYT Amazings (Espanha): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (09/Mar/2020)
Catalunya Vanguardista (Espanha): Veneno de serpiente cascabel para tratar el dolor crónico (09/Mar/2020)
AuroBlog: We Just Got Closer to Producing Painkillers From Rattlesnake Venom (24/Feb/2020)
Herencia Genetica y Enfermedad (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (24/Feb/2020)
International Business Times (Singapura): Snakes or life savers? New painkillers from Rattlesnake venom may provide relief to millions (23/Feb/2020)
ScienceAlert (Austrália): We Just Got Closer to Producing Painkillers From Rattlesnake Venom (22/Feb/2020)
Daniel Aleart (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (19/Feb/2020)
Buffalo X Press: Brazilian Researchers Prove Crotoxin’s Therapeutic Effects Can Cure Chronic Pain (19/Feb/2020)
SerTox (Argentina): Logran mejor efecto analgésico de la crotoxina al encapsularla en sílice nanoestructurada (18/Feb/2020)
Newstes (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
SerTox (Argentina): Better analgesic effect of crotoxin by encapsulating it in nanostructured silica, study (18/Feb/2020)
Polit News (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
Science Bulletin: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (18/Feb/2020)
Vechnayamolodost (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
UGPressa (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
Polit (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
IntraMed (Argentina): Estudio en animales con veneno de serpiente de cascabel | Nueva formulación de Crotoxina para tratar el dolor crónico (17/Feb/2020)
Small Tech News: Rattlesnake venom complex or can become a new effective painkiller (17/Feb/2020)
European Pharmaceutical Review: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
Phys.Org (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (17/Feb/2020)
Archyworldys: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
PressBoltNews (Índia): Health and medical Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
Technologie Média: Un nouvel analgésique venant du serpent à sonnette (17/Feb/2020)
FarsNews Agency (Irã): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
Bioquick News (EUA): Novel Formulation Permits Use of Toxin from Rattlesnake Venom to Treat Chronic Pain (17/Feb/2020)
RCTopNews: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Feb/2020)
News Medical (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Feb/2020)
Tech Sina (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Vijayawada Now (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Kejik.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Obor News: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Feb/2020)
KE jūn I zhāiyào: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Blog WONGCW (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Trap Town (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Zaker (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Xiang Fang News (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
HEA - Health Essence of Asia Group (Taiwan): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Alien Gossip (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Caiyisou (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
FBI Reform (EUA): Eurasia Review: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Feb/2020)
Bizsiziz: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
SOHU.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Lab Manager (Canadá): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Bio1000 (China): 新的配方允许使用响尾蛇毒液中的毒素治疗慢性疼痛 (15/Feb/2020)
System Daquan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Medindia (Índia): Toxin from Rattlesnake Venom to Treat Chronic Pain (15/Feb/2020)
WNDU 16 (EUA): Toxin From Rattlesnake Venom Formulated to Treat Chronic Pain (15/Feb/2020)
Niuzhan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
cnBeta (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
The WB Mirror: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
QQ.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Xoer (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Long Room (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
RCTopNews: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
SciTech Daily (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
7thSpace: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Bioengineer (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
HNewspaper: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Nanotechnology Now (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Scienmag Science Magazine (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Scienstack: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Daily Tend (Paquistão): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Pharma Jobs: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
New Atlas (Austrália): Rattlesnake venom compound points to promising new painkiller (14/Feb/2020)
Eurasia Review (Espanha): Using Toxin From Rattlesnake Venom To Treat Chronic Pain (14/Feb/2020)
Tech Deeps: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Science Codex: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Health Medicine Network (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated September 19, 2020
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (2)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications2
Citations5
Cit./Article2.5
Data from Web of Science

KIMURA, LOUISE FAGGIONATO; DE MOURA MATTARAIA, VANIA GOMES; PICOLO, GISELE. Distinct environmental enrichment protocols reduce anxiety but differentially modulate pain sensitivity in rats. Behavioural Brain Research, v. 364, p. 442-446, . Web of Science Citations: 5. (11/17974-2, 08/57898-0, 13/20795-8)

KIMURA, LOUISE FAGGIONATO; SANT'ANNA, MORENA BRAZIL; ZAMBELLI, VANESSA OLZON; GIARDINI, ALINE CAROLINA; SILVA JARED, SIMONE GONCALVES; ANTONIAZZI, MARTA MARIA; DE MOURA MATTARAIA, VANIA GOMES; PAGANO, ROSANA LIMA; PICOLO, GISELE. Early exposure to environmental enrichment protects male rats against neuropathic pain development after nerve injury. Experimental Neurology, v. 332, . Web of Science Citations: 0. (13/07467-1, 08/57898-0, 13/20795-8)

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: